All articles tagged with #alex denner
Biogen shareholders have elected Susan Langer, the romantic partner of departing director Alex Denner, to its board of directors for a one-year term. The decision has raised concerns among some investors and former employees of the company, who were not informed of the relationship when Langer's candidacy was announced.
Biogen, a biotech company, has nominated Susan Langer, the live-in romantic partner of departing board member Alex Denner, to replace him on the board. Langer is also the daughter of biotech inventor and billionaire Bob Langer. Biogen did not disclose the relationship between Denner and Langer in its SEC filing, and the nomination has raised questions about the company's corporate governance practices. Three former Biogen executives expressed shock at Langer's nomination, citing her lack of qualifications and experience.
Biogen's nominee to replace longtime director Alex Denner on its board, Susan Langer, is Denner's live-in romantic partner and the mother of his child, according to court records. Biogen knew about the relationship but did not disclose it to shareholders before they vote on Langer's candidacy later this month. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons.
Biogen has added Susan Langer to its board of directors, replacing longtime member Alex Denner. Langer has an extensive background in biotech, including a corporate role at Biogen, but is also Denner's romantic partner, according to sources.
Biogen's board shakeup continues as Alex Denner, Richard Mulligan, and William Jones are leaving the board. Denner, who spearheaded Carl Icahn's bid to engineer a tumultuous turnaround, was first elected to the board in 2009. The shakeup comes as new CEO Michel Vounatsos crafts a fresh board with Susan Langer and Caroline Dorsa.